Endovascular Therapeutics India Private Limited
About Endovascular Therapeutics India Private Limited
Data last updated:
Endovascular Therapeutics India Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the real estate leasing and property management segment of the real estate sector. It was incorporated on 20 April 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33112MH2000PTC126063. Its GSTIN is 27AAACE6945R1ZX (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹46.04 Lakh. It is led by directors including Sam Mathew and Bina Mathew.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ioma Plot No F/915 F.P.No: 116 Tps III Prof. Almeida Road Bandra West, Mumbai, Maharashtra, India – 400050.
As per the financials filed for FY 2024, the company reported a revenue of ₹86.42 Lakh, a growth of 117% compared to the previous year. For the same year it recorded a net profit of ₹70.81 Lakh (net margin 81.9%) and EBITDA of ₹83.9 Lakh (EBITDA margin 97.1%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 23% over five years.
As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹2.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Endovascular Therapeutics India Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressIoma Plot No F/915 F.P.No: 116 Tps III Prof. Almeida Road Bandra West, Mumbai, Maharashtra, India – 400050
- IndustryReal Estate, Real Estate Leasing
To see the full contact details of Endovascular Therapeutics India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Endovascular Therapeutics India is real estate. In detail, this covers real estate activities with own or leased property.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| L | Real Estate | L1 | Real estate activities with own or leased property |
To see the full business activity and turnover split of Endovascular Therapeutics India Private Limited, buy the company report.
Financials of Endovascular Therapeutics India Private Limited
FY 2025 filings availableEndovascular Therapeutics India Private Limited reported revenue of ₹86.42 Lakh (up 117% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 117% growth in the latest year. EBITDA rose 178% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹83.9 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹70.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 97.1% | ||||
| Net Profit Margin | 81.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Endovascular Therapeutics India Private Limited, buy the company report.
Board of directors of Endovascular Therapeutics India Private Limited
Endovascular Therapeutics India has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sam Mathew | Director | 26 Aug 2014 | 12 Years 2 Months | Current |
| Bina Mathew | Director | 27 Aug 2008 | 18 Years 2 Months | Current |
| Merinsam Mathew | Additional Director | 10 Jan 2026 | 0 Years 9 Months | Current |
Peer comparison
Endovascular Therapeutics India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (real estate activities with own or leased property), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Build-All Madras Private Limited | ₹86.53 Lakh (FY 2025) | 30.0% | Chennai, Tamil Nadu, India | |||
| Mansarover Builders Private Limited | ₹86.52 Lakh (FY 2025) | 20.0% | New Delhi, Delhi, India | |||
| Monika Resources Pvt Ltd | ₹86.48 Lakh (FY 2025) | 127.0% | Kolkata, West Bengal, India | |||
| Elita Garden Vista Project Private Limited | ₹86.46 Lakh (FY 2025) | -48.0% | Kolkata, West Bengal, India | |||
| Sharma Housing (India) Private Limited | ₹86.43 Lakh (FY 2025) | 20776.0% | Dehradun, Uttarakhand, India | |||
| Endovascular Therapeutics India Private Limitedthis company | ₹86.42 Lakh (FY 2024) | ₹70.81 Lakh | 81.9% | 117.0% | Mumbai, Maharashtra, India | |
| GTV Properties Private Limited | ₹86.41 Lakh (FY 2023) | 11.0% | Bangalore, Karnataka, India | |||
| Rose Rock Real Estate India Private Limited | ₹86.37 Lakh (FY 2024) | 3794.0% | Mumbai, Maharashtra, India | |||
| Danj Software Private Limited | ₹86.34 Lakh (FY 2024) | 1.0% | New Delhi, Delhi, India | |||
| Birla Spaces Private Limited | ₹86.33 Lakh (FY 2025) | -28.0% | Pune, Maharashtra, India | |||
| King Fisher Polymers Private Limited | ₹86.31 Lakh (FY 2024) | 9.0% | Faridabad, Haryana, India |
To see the full peer comparison of Endovascular Therapeutics India Private Limited, buy the company report.
Auditor
Endovascular Therapeutics India Private Limited is audited by ANJU P KAPADIA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANJU P KAPADIA | FY 2017 | 042203 |
Shareholding
The shareholding of Endovascular Therapeutics India Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Endovascular Therapeutics India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jan 2003 | 90148138 | Union Bank of India | ₹50 Lakh | Open | |
| 21 Nov 2002 | 90141070 | Union Bank of India | ₹2.5 Cr | Satisfied |
To see the full charge records of Endovascular Therapeutics India Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Endovascular Therapeutics India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Endovascular Therapeutics India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Endovascular Therapeutics India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACE6945R1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Endovascular Therapeutics India Private Limited, buy the company report.
Recent activity
Endovascular Therapeutics India Private Limited has 6 board changes on record since 2008: 4 appointments and 2 cessations. The latest: Merinsam Mathew was appointed as Additional Director on 10 Jan 2026.
1 earlier event is in the company report.
Frequently asked questions
Endovascular Therapeutics India is an active private limited company based in Mumbai, Maharashtra, India. The company works in real estate leasing, within the real estate industry. It was incorporated on 20 April 2000 (26+ years old) and is registered under CIN U33112MH2000PTC126063.
Endovascular Therapeutics India has 3 current directors:
- Sam Mathew - Director
- Bina Mathew - Director
- Merinsam Mathew - Additional Director
The latest financial statements of Endovascular Therapeutics India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Endovascular Therapeutics India is 27AAACE6945R1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Endovascular Therapeutics India is U33112MH2000PTC126063. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Endovascular Therapeutics India was incorporated on 20 April 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Endovascular Therapeutics India by revenue are Build-All Madras Private Limited, Mansarover Builders Private Limited, Monika Resources Pvt Ltd, Elita Garden Vista Project Private Limited, Sharma Housing (India) Private Limited and 5 more, all in the same principal business activity (real estate activities with own or leased property).
Merinsam Mathew was appointed as Additional Director on 10 Jan 2026. Sam Mathew was appointed as Director on 26 Aug 2014. Iqbal Kasim ceased to be Director on 31 Aug 2008. Endovascular Therapeutics India has 6 board changes on record in total.
The registered office of Endovascular Therapeutics India is at Ioma Plot No F915 F.P.No: 116 Tps III Prof. Almeida Road Bandra West, Mumbai, Maharashtra, India – 400050.
Endovascular Therapeutics India operates in the real estate industry, in the real estate leasing segment.
Endovascular Therapeutics India has open charges of ₹50 Lakh and satisfied charges of ₹2.5 Cr as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
